We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Making the Switch to In-House Mycoplasma Testing content piece image
Whitepaper

Making the Switch to In-House Mycoplasma Testing

Many regulatory guidelines state that cell banks and cultures used in the production of biologics must be tested for mycoplasma. Mycoplasma infections can cause severe problems in manufacturing as these organisms can alter DNA, RNA and modify host cell plasma membrane antigens.
Delivering the Future of Genomic Pathogen Surveillance content piece image
Whitepaper

Delivering the Future of Genomic Pathogen Surveillance

Serious infectious disease outbreaks have been an ever-present threat throughout human history and, driven by factors such as increasing globalization, population growth, urbanization and climate change, that threat is increasing.
Human Whole Transcriptome Atlas content piece image
Whitepaper

Human Whole Transcriptome Atlas

GeoMx® Human Whole Transcriptome Atlas

Traditional gene expression technologies are unable to capture heterogeneity of the transcriptome with spatial context.
Milestones in Spatial Biology content piece image
Whitepaper

Milestones in Spatial Biology

Spatially resolved biology allows researchers to study cells in the context of their tissue microenvironment, enabling a fuller appreciation of cellular function.
Accelerating Cancer Research Through Comprehensive Genomic Analysis content piece image
Whitepaper

Accelerating Cancer Research Through Comprehensive Genomic Analysis

While next-generation sequencing is becoming increasingly routine in cancer research laboratories, it fails to address a number of key genomic drivers or markers of cancer, such as structural variations, DNA methylation and transcript isoforms.
CRISPR Antibiotics: Turning Defense Into Offence content piece image
Whitepaper

CRISPR Antibiotics: Turning Defense Into Offence

Download this whitepaper to discover how CRISPR can overcome antibiotic-resistant and pathogenic bacteria.
Reagent Manufacturing for a Novel CRISPR-Based Diagnostic SARS CoV-2 Test content piece image
Whitepaper

Reagent Manufacturing for a Novel CRISPR-Based Diagnostic SARS CoV-2 Test

Download this whitepaper to discover how the manufacturing process was successfully scaled using operational support, a customized solution as well as a highly collaborative and strategic engagement.
How CRISPR Can Help the Switch to Sustainable Cosmetics content piece image
Whitepaper

How CRISPR Can Help the Switch to Sustainable Cosmetics

The global cosmetics industry is worth more than $500 billion, but relies on ingredients that are unsustainable and cause harm to plant and animal life. Growing awareness of this problem among consumers has fueled a demand for something different.
Streamline Antibody Labeling Workflows content piece image
Whitepaper

Streamline Antibody Labeling Workflows

Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.
Improving Efficiency in Drug Discovery and Preclinical Development content piece image
Whitepaper

Improving Efficiency in Drug Discovery and Preclinical Development

Creating and bringing new drugs to the market can bring huge productivity challenges as the already complex drug development process becomes lengthier and more expensive.
Advertisement